GRECO, MARIANNA
 Distribuzione geografica
Continente #
EU - Europa 23.084
NA - Nord America 918
AS - Asia 175
AF - Africa 2
Totale 24.179
Nazione #
IT - Italia 22.903
US - Stati Uniti d'America 913
CN - Cina 106
SE - Svezia 77
SG - Singapore 34
FI - Finlandia 28
UA - Ucraina 27
VN - Vietnam 22
GB - Regno Unito 14
DE - Germania 10
CZ - Repubblica Ceca 7
BE - Belgio 6
FR - Francia 6
CA - Canada 5
KR - Corea 5
IN - India 3
IR - Iran 3
AT - Austria 2
NL - Olanda 2
SA - Arabia Saudita 2
CI - Costa d'Avorio 1
IE - Irlanda 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 24.179
Città #
Cagliari 22.306
Uta 491
Fairfield 128
Woodbridge 89
Chandler 73
Seattle 72
Ashburn 63
Ann Arbor 54
Wilmington 53
Boardman 51
Cambridge 51
Houston 51
Nyköping 51
Shanghai 30
New York 28
Dong Ket 22
Helsinki 21
Dearborn 18
Singapore 17
Milan 15
Santa Clara 15
Beijing 14
Jacksonville 10
Boston 9
Nanjing 7
Brussels 6
San Diego 6
Guangzhou 5
Prague 5
Redmond 5
Rome 5
Seoul 5
Toronto 5
Changsha 4
Falls Church 4
London 4
Los Angeles 4
Phoenix 4
Wuhan 4
Bischheim 3
Genoa 3
Hefei 3
Kunming 3
Macomer 3
Mountain View 3
Nanchang 3
Norwalk 3
Quartu Sant'Elena 3
Redwood City 3
Sassari 3
Amsterdam 2
Arbus 2
Carbonia 2
Civitanova Marche 2
Collegno 2
Gossolengo 2
Hebei 2
Jinan 2
Ningbo 2
Oliena 2
Osimo 2
Peschiera Borromeo 2
Pune 2
Riyadh 2
Tianjin 2
Umeå 2
Vienna 2
Washington 2
Abidjan 1
Assemini 1
Augusta 1
Biassono 1
Blackheath 1
Boksburg 1
Bologna 1
Brno 1
Centro 1
Chicago 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Dublin 1
Espoo 1
Frankfurt am Main 1
Hounslow 1
Islington 1
Jiaxing 1
Lappeenranta 1
Leawood 1
Lissone 1
Modugno 1
Munich 1
New Orleans 1
Olmedo 1
Olomouc 1
Paris 1
Quartu Sant'elena 1
Sacramento 1
San Mateo 1
Sestu 1
Taizhou 1
Totale 23.906
Nome #
HLA-G expression and role in advanced-stage classical Hodgkin lymphoma 3.474
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients 3.242
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.183
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients 2.471
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.058
Ruxolitinib therapy and telomere length in myelofibrosis 1.818
Systemic Mastocytosis with Associated Primary Myelofibrosis 1.462
null 1.419
Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia 1.209
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.061
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis 694
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine 486
Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib? 486
Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation 450
Clinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification during pregnancy 391
Bone marrow homing and engraftment defects of human hematopoietic stem and progenitor cells 343
Totale 24.247
Categoria #
all - tutte 29.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.674 0 0 0 0 1.251 1.102 642 157 105 129 102 186
2020/20217.261 227 386 355 2.118 1.282 785 381 468 200 521 340 198
2021/20221.827 213 106 62 122 174 111 81 85 182 276 247 168
2022/20232.272 136 313 288 220 168 238 136 152 151 143 216 111
2023/20242.082 91 115 71 138 201 371 310 161 118 124 194 188
2024/20252.371 528 617 604 460 162 0 0 0 0 0 0 0
Totale 24.247